Pay in 4 interest-free payments of $6.84 Learn more
Ships within 48 hours · Estimated delivery Sep 6 - Sep 11
For weight management , certain GLP-1 formulations (liraglutide 3.0mg [Saxenda] and semaglutide 2.4mg [Wegovy]) are licensed for chronic weight management in adults with: BMI 30 kg/m , or BMI 27 kg/m with at least one weight-related comorbidity (such as type 2 diabetes, hypertension, or dyslipidaemia) However, NHS access to these medications for weight management is typically restricted to specialist tier 3 or tier 4 weight management services, with specific eligibility criteria defined by NICE technology appraisals (TA494 for liraglutide, TA664 for semaglutide) and local commissioning arrangements
Each vial contains 10 mg of compound
Increasing heart rate Worsening depression, behavior changes, or suicidality Note: Never share the Mounjaro pen with other people
Consent to publish N/A
US$ 27.29
US$ 22.29
US$ 25.84
US$ 21.56
US$ 23.01
US$ 28.07
